Next Article in Journal / Special Issue
NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives
Previous Article in Journal / Special Issue
Endovascular Thrombectomy Following Acute Ischemic Stroke: A Single-Center Case Series and Critical Review of the Literature
Brain Sci. 2013, 3(2), 540-560; doi:10.3390/brainsci3020540
Review

Stroke Neuroprotection: Targeting Mitochondria

1,2,3,* , 3
, 4
 and 3
Received: 8 March 2013; in revised form: 8 April 2013 / Accepted: 9 April 2013 / Published: 19 April 2013
(This article belongs to the Special Issue Neuroprotection against Ischemic Brain Injury)
View Full-Text   |   Download PDF [958 KB, uploaded 19 April 2013]   |   Browse Figures
Abstract: Stroke is the fourth leading cause of death and the leading cause of long-term disability in the United States. Blood flow deficit results in an expanding infarct core with a time-sensitive peri-infarct penumbra that is considered salvageable and is the primary target for treatment strategies. The only current FDA-approved drug for treating ischemic stroke is recombinant tissue plasminogen activator (rt-PA). However, this treatment is limited to within 4.5 h of stroke onset in a small subset of patients. The goal of this review is to focus on mitochondrial-dependent therapeutic agents that could provide neuroprotection following stroke. Dysfunctional mitochondria are linked to neurodegeneration in many disease processes including stroke. The mechanisms reviewed include: (1) increasing ATP production by purinergic receptor stimulation, (2) decreasing the production of ROS by superoxide dismutase, or (3) increasing antioxidant defenses by methylene blue, and their benefits in providing neuroprotection following a stroke.
Keywords: stroke; purinergic receptor; methylene blue; mitochondria; neuroprotection; superoxide dismutase stroke; purinergic receptor; methylene blue; mitochondria; neuroprotection; superoxide dismutase
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Watts, L.T.; Lloyd, R.; Garling, R.J.; Duong, T. Stroke Neuroprotection: Targeting Mitochondria. Brain Sci. 2013, 3, 540-560.

AMA Style

Watts LT, Lloyd R, Garling RJ, Duong T. Stroke Neuroprotection: Targeting Mitochondria. Brain Sciences. 2013; 3(2):540-560.

Chicago/Turabian Style

Watts, Lora T.; Lloyd, Reginald; Garling, Richard J.; Duong, Timothy. 2013. "Stroke Neuroprotection: Targeting Mitochondria." Brain Sci. 3, no. 2: 540-560.


Brain Sci. EISSN 2076-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert